Feature Paper in Antibiotics for 2019

There has been much speculation about a possible antibiotic Armageddon; this would be the result of having untreatable post-operative infections, and similarly untreatable complications after chemotherapy. The now famous “O’Neill Report” (https://amr-review.org/) suggests that more people could die...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (282 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545835204498
ctrlnum (CKB)5400000000044635
(oapen)https://directory.doabooks.org/handle/20.500.12854/69089
(EXLCZ)995400000000044635
collection bib_alma
record_format marc
spelling Lipman, Jeffrey edt
Feature Paper in Antibiotics for 2019
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
1 electronic resource (282 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
There has been much speculation about a possible antibiotic Armageddon; this would be the result of having untreatable post-operative infections, and similarly untreatable complications after chemotherapy. The now famous “O’Neill Report” (https://amr-review.org/) suggests that more people could die from resistant bacterial infections by 2050 than from cancer. We are still learning about all the subtle drivers of antibiotic resistance, and realizing that we need a single “whole of health” co-ordinated policy. We ingest what we sometimes feed to animals. There do not seem to be any new classes of antibiotics on our horizon. Perhaps something that has been around “forever” will come to our rescue—bacteriophages! Nevertheless, we have to do things differently, use antibiotics appropriately, for the correct indication, for the correct duration and with the correct dose, and with that, practice good antibiotic stewardship. Whilst by no means comprehensive, this book does cover some of the many topics of antibiotic stewardship. It also addresses some of the older antibiotics, some new combinations, and even some new agents. Last, and by no means least, there are two excellent articles on bacteriophages.
English
Medicine bicssc
Antimicrobial resistance
antibiotics
antimicrobial stewardship
inappropriate prescribing
days of therapy
Start Smart then Focus
piperine
piperlongumine
antibacterial
antifungal
synergy
non-target feed
florfenicol
thiamfenicol
chloramfenicol
HPLC-MS/MS
validation
swine
out-of-hours care
primary care
quality of care
quality indicators
practitioners cooperative
antibiotic stewardship
fluoroquinolones
guidelines
urinary tract infections
quality improvement
general practitioners
guideline
health inequalities
health equity assessment tool
public health
Enterobacteriaceae
carbapenem-resistant
CRE
antibiotic resistance
antimicrobials
bacteriophages
biofilms
novel antimicrobials
Antibiotics
resistance
broad-spectrum agents
hospital epidemiology
antibiotic utilization
infection control
infection prevention
Pseudomonas aeruginosa
Acinetobacter baumannii
extended-spectrum beta-lactamases
carbapenem-resistant Enterobacteriaceae
methicillin-resistant Staphylococcus aureus
clinical trials
infectious disease
phage therapy
silver complexes
camphorimine
anti-Candida activity
antifungals
antibacterials
efflux inhibitors
efflux pumps
erm(41)
mutations
mycobacteria
verapamil
actinomycetes
bioactivity
polyketides
polyketide synthases
biosynthesis
antimicrobial resistance
economic evaluation
cost-utility analysis
cost-effectiveness analysis
policy analysis
One Health
Singapore
antibiotic prescribing
implementation
behavior change
stakeholder consultation
3-03943-122-6
3-03943-123-4
Lipman, Jeffrey oth
language English
format eBook
author2 Lipman, Jeffrey
author_facet Lipman, Jeffrey
author2_variant j l jl
author2_role Sonstige
title Feature Paper in Antibiotics for 2019
spellingShingle Feature Paper in Antibiotics for 2019
title_full Feature Paper in Antibiotics for 2019
title_fullStr Feature Paper in Antibiotics for 2019
title_full_unstemmed Feature Paper in Antibiotics for 2019
title_auth Feature Paper in Antibiotics for 2019
title_new Feature Paper in Antibiotics for 2019
title_sort feature paper in antibiotics for 2019
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2020
physical 1 electronic resource (282 p.)
isbn 3-03943-122-6
3-03943-123-4
illustrated Not Illustrated
work_keys_str_mv AT lipmanjeffrey featurepaperinantibioticsfor2019
status_str n
ids_txt_mv (CKB)5400000000044635
(oapen)https://directory.doabooks.org/handle/20.500.12854/69089
(EXLCZ)995400000000044635
carrierType_str_mv cr
is_hierarchy_title Feature Paper in Antibiotics for 2019
author2_original_writing_str_mv noLinkedField
_version_ 1787548474313539584
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04940nam-a2201285z--4500</leader><controlfield tag="001">993545835204498</controlfield><controlfield tag="005">20231214133228.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044635</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69089</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044635</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lipman, Jeffrey</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Feature Paper in Antibiotics for 2019</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (282 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">There has been much speculation about a possible antibiotic Armageddon; this would be the result of having untreatable post-operative infections, and similarly untreatable complications after chemotherapy. The now famous “O’Neill Report” (https://amr-review.org/) suggests that more people could die from resistant bacterial infections by 2050 than from cancer. We are still learning about all the subtle drivers of antibiotic resistance, and realizing that we need a single “whole of health” co-ordinated policy. We ingest what we sometimes feed to animals. There do not seem to be any new classes of antibiotics on our horizon. Perhaps something that has been around “forever” will come to our rescue—bacteriophages! Nevertheless, we have to do things differently, use antibiotics appropriately, for the correct indication, for the correct duration and with the correct dose, and with that, practice good antibiotic stewardship. Whilst by no means comprehensive, this book does cover some of the many topics of antibiotic stewardship. It also addresses some of the older antibiotics, some new combinations, and even some new agents. Last, and by no means least, there are two excellent articles on bacteriophages.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Antimicrobial resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial stewardship</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inappropriate prescribing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">days of therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Start Smart then Focus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">piperine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">piperlongumine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibacterial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antifungal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">synergy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-target feed</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">florfenicol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thiamfenicol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chloramfenicol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HPLC-MS/MS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">validation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">swine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">out-of-hours care</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">primary care</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quality of care</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quality indicators</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">practitioners cooperative</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic stewardship</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fluoroquinolones</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">guidelines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urinary tract infections</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quality improvement</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">general practitioners</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">guideline</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">health inequalities</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">health equity assessment tool</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">public health</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Enterobacteriaceae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carbapenem-resistant</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CRE</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacteriophages</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biofilms</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">novel antimicrobials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Antibiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">broad-spectrum agents</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hospital epidemiology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic utilization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infection control</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infection prevention</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pseudomonas aeruginosa</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Acinetobacter baumannii</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">extended-spectrum beta-lactamases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carbapenem-resistant Enterobacteriaceae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">methicillin-resistant Staphylococcus aureus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical trials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infectious disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">silver complexes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">camphorimine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-Candida activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antifungals</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibacterials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">efflux inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">efflux pumps</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">erm(41)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mutations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mycobacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">verapamil</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">actinomycetes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioactivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyketides</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyketide synthases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biosynthesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">economic evaluation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cost-utility analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cost-effectiveness analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">policy analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">One Health</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Singapore</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic prescribing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">implementation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">behavior change</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">stakeholder consultation</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-122-6</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-123-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lipman, Jeffrey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:47:08 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338103080004498&amp;Force_direct=true</subfield><subfield code="Z">5338103080004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338103080004498</subfield></datafield></record></collection>